New insights into the role of ID proteins in breast cancer metastasis: a MET affair

Breast Cancer Res. 2014 May 15;16(2):305. doi: 10.1186/bcr3654.

Abstract

The establishment of lethal metastases depends on the capacity of a small number of cancer cells to regenerate a tumor after entering a target organ. Stankic and colleagues have identified a role for the inhibitor of differentiation protein, ID1, as a critical regulator of breast cancer stem-like properties and metastatic colonization. Under the control of tumor growth factor-beta signaling, ID1 induces mesenchymal-epithelial transition at the metastatic site by antagonizing the activity of the basic helix-loop-helix transcription factor Twist1. This study sheds light on mechanisms that initiate metastatic outgrowth, and strengthens the concept that epithelial-mesenchymal plasticity is crucial at different stages of metastasis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Breast Neoplasms / metabolism*
  • Epithelial-Mesenchymal Transition*
  • Female
  • Humans
  • Inhibitor of Differentiation Protein 1 / metabolism*
  • Lung Neoplasms / secondary*
  • Nuclear Proteins / metabolism*
  • Transforming Growth Factor beta / metabolism*
  • Twist-Related Protein 1 / metabolism*

Substances

  • Inhibitor of Differentiation Protein 1
  • Nuclear Proteins
  • Transforming Growth Factor beta
  • Twist-Related Protein 1